结题验收信息 |
获得的标志性成果 |
[1] Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway,2021年1月,Biomedicine and Pharmacotherapy,SCI II区,1 [2]罗益远, 陈宏降, 杨颖欣,等. 基于QTRAP UPLC-MS/MS的乌药不同部位中生物碱,内酯类和黄酮类成分分析[J]. 中国药学杂志, 2021, 56(11):6. [3] Furong Wang, Juan Wang, Hongdie Cai, Lixia Yuan, Chonglu Sun, Xin Peng ,Weiwei Yan, Jiale Zhang. Network pharmacology combined with metabolomics to investigate the anti-hyperlipidemia mechanism of a novel combination. Journal of Functional Foods,2021,87,104848. [4]罗益远,蔡红蝶,沙秀秀,陈宏降,沈旭立,周根,彭昕.天台乌药不同部位挥发性成分的GC-MS分析[J].中药材,2019,42(06):1319-1322.DOI:10.13863/j.issn1001-4454.2019.06.022. |